No black box warning on record for Microgestin Fe 1.5/30

As of the latest FDA labeling reviewed, Microgestin Fe 1.5/30 (NORETHINDRONE ACETATE/ETHINYL ESTRADIOL AND FERROUS FUMARATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Microgestin Fe 1.5/30 medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS The use of oral contraceptives is associated with increased risks of several serious conditions including myocardial infarction, thromboembolism, stroke, hepatic neoplasia, and gallbladder disease, although the risk of serious morbidity or mortality is very small in healthy women without underlying risk factors. The risk of morbidity and mortality increases significantly in the presence o

No black box warning on record for Microgestin Fe 1.5/30

Other warnings & precautions

WARNINGS The use of oral contraceptives is associated with increased risks of several serious conditions including myocardial infarction, thromboembolism, stroke, hepatic neoplasia, and gallbladder disease, although the risk of serious morbidity or mortality is very small in healthy women without underlying risk factors. The risk of morbidity and mortality increases significantly in the presence o

Microgestin Fe 1.5/30 Black Box Warning

No black box warning on record for Microgestin Fe 1.5/30

Other warnings & precautions

Microgestin Fe 1.5/30 Black Box Warning

No black box warning on record for Microgestin Fe 1.5/30

Other warnings & precautions